Form 8-K - Current report:
SEC Accession No. 0001558370-18-009004
Filing Date
2018-11-08
Accepted
2018-11-08 16:07:04
Documents
2
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 39018
2 EX-99.1 ex-99d1.htm EX-99.1 177204
  Complete submission text file 0001558370-18-009004.txt   217372
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 181169715
SIC: 2834 Pharmaceutical Preparations